| Income Statement |
| Operating Expenses | 6.54M |
|
| Research and Development Expense | 4.37M |
| Selling, General and Administrative Expense | 2.17M |
| Operating Income | -6.54M |
| Net Income | -6.49M |
| Net Income Common Stock | -6.49M |
| Net Income Common Stock (USD) | -6.49M |
| Consolidated Income | -6.49M |
| Earnings per Basic Share | -1.19 |
| Earnings per Basic Share (USD) | -1.19 |
| Earnings per Diluted Share | -1.19 |
| Earning Before Interest & Taxes (EBIT) | -6.49M |
| Earning Before Interest & Taxes (USD) | -6.49M |
| Weighted Average Shares | 5.45M |
| Weighted Average Shares Diluted | 5.45M |
| Balance Sheet |
| Cash and Equivalents | 3.92M |
| Cash and Equivalents (USD) | 3.92M |
| Current Assets | 4.85M |
| Property, Plant & Equipment Net | 7.35M |
| Total Assets | 12.25M |
| Debt Current | 278.00K |
| Total Debt | 278.00K |
| Current Liabilities | 1.49M |
| Total Liabilities | 1.49M |
| Accumulated Retained Earnings (Deficit) | -119.48M |
| Shareholders Equity | 10.76M |
| Shareholders Equity (USD) | 10.76M |
| Assets Non-Current | 7.41M |
| Total Debt (USD) | 278.00K |
| Trade and Non-Trade Payables | 604.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 501.00K |
| Net Cash Flow from Financing | 3.64M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.02M |
| Capital Expenditure | -688.00K |
| Issuance (Purchase) of Equity Shares | 3.66M |
| Net Cash Flow from Investing | -688.00K |
| Net Cash Flow from Operations | -5.97M |
| Share Based Compensation | 447.00K |